EVALUATION THE OUTCOMES OF SURGERY FOR STAGE I AND II MAXILLARY SINUS CARCINOMA AT ENT SURGERY DEPARTMENT - VIETNAM NATIONAL CANCER HOSPITAL

Thị Tiến Kim1, , Tiến Hùng Nguyễn 1, Văn Nhạ Hoàng1, Trung Dũng Trần1
1 Khoa Ngoại Tai Mũi Họng, Bệnh viện K Tân Triều

Main Article Content

Abstract

Objective: Evaluation of clinical characteristics, histopathology and surgical outcomes of stage I and II maxillary sinus carcinoma at ENT Surgery Department of Vietnam National Cancer Hospital. Materials and Methods: A study involving 31 patients on stage I and II maxillary sinus carcinoma at ENT Surgery Department of Vietnam National Cancer Hospital from June 2021 to June 2024. Descriptive study with intervention. Results: Patient’s ages ranged from 24 to 66 years old, average 49,19 ± 9,77, with 67,74% being male. Facial pressure accounted for 64,52%. SCC is the most common, accounting for 83,87%. In 2 cases of endoscopic surgery combined with lateral rhinotomy incision, 100% had damaged tear duct, without need for a feeding tube or tracheotomy. In 17 cases with Caldwell-Luc incision, 47,06% had damaged tear duct, 29,41% needed tracheotomy, nasogastric tube placement and reconstruction, of which 11,76% needed immediate reconstruction and 17,65% had an artificial replacement. In 12 cases with Weber Ferguson incision, 83,33% had damaged tear duct, 41,67% needed tracheotomy, nasogastric tube placement, 75% needed reconstruction, of which 50% needed immediate reconstruction, 8,33% had delayed reconstruction and 16,67% had an artificial replacement. Complications post- endoscopic surgery include blocked / runny nose, while other operations had complications including blocked / runny nose, numb face / lips, deformed face and choking. Conclusion: SCC is the most common maxillary sinus carcinoma, with poor symptoms. Surgery in early stage for maxillary sinus carcinoma had good results with fewer complications and the patients’ quality of life was less affected.

Article Details

References

1. Dulguerov P, Jacobsen MS, Allal AS, et al. Nasal and paranasal sinus carcinoma: Are we making progress? A series of 220 patients and a systematic review. American Cancer Society. 2001; 92(12):3012-3029.
2. Brierley JD, Gospodarowicz MK and Wittekind C. TNM classification of malignant tumours. Wiley Blackwell. 2017; 8.
3. Wang Y, Yang R, Zhao M, et al. Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration. World Journal of Surgical Oncology. 2020; 18:1-8.
4. Nguyễn Thế Đạt. Nghiên cứu một số đặc điểm lâm sàng, cận lâm sàng và tình trạng đột biến gen EGFR ở bệnh nhân ung thư biểu mô vảy mũi xoang. Luận án Tiến sĩ Y học, Trường Đại học Y Hà Nội. 2022.
5. Ho AS, Zanation AM and Ganly I. Malignancies of the paranasal sinus. Cummings Otolaryngology - Head and Neck Surgery. Saunders. 2015; 1.
6. Akinmoladun VI, Akinyamoju CA, Olaniran FO, et al. Maxillectomy and quality of life: Experience from a Nigerian tertiary institution. Nigerian Journal of Surgery. 2018; 24(2):125-130.
7. Jimson S, Krishnan L, Jimson S, et al. Maxillectomy. Biomedical and Pharmacology Journal. 2015; 8:161-167.
8. Ali MM, Khalifa N and Alhajj MN. Quality of life and problems associated with obturators of patients with maxillectomies. Head and Face Medicine. 2018; 14(2):1-9.